(Q38668258)

5 September 2017

microRNA and Pulmonary Hypertension (English)

1 reference

5 September 2017

1 reference

Olivier Boucherat

1

1 reference

5 September 2017

François Potus

series ordinal

2

1 reference

5 September 2017

Sébastien Bonnet

series ordinal

3

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 January 2015

1 reference

Advances in Experimental Medicine and Biology

5 September 2017

1 reference

5 September 2017

888

1 reference

5 September 2017

237-252

1 reference

Diagnosis and assessment of pulmonary arterial hypertension.

5 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Exercise intolerance in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Relevant issues in the pathology and pathobiology of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNAs in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Inhibition of microRNA-125a promotes human endothelial cell proliferation and viability through an antiapoptotic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Alterations of cellular bioenergetics in pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Role for miR-204 in human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Krüppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Role for DNA damage signaling in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Notch3 signaling promotes the development of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Loss of microRNA-17∼92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Role of K+ channels in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells against apoptosis via HSP90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

miR-223 reverses experimental pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

A Role for miR-145 in Pulmonary Arterial Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K⁺ channel in arterial smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22671-2_12

10.1007/978-3-319-22671-2_12

31 March 2020

Identifiers

DOI

1 reference

5 September 2017

1 reference